Jatt Acquisition Corp Cl A (JATT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JATT | ABOS | IVA | ||
| Company | Jatt Acquisition Corp Cl A | Acumen Pharmaceuticals Inc | Inventiva S.A. ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 10.38 | 2.30 | 2.56 | ||
| High | 10.51 | 2.38 | 2.62 | ||
| Low | 7.80 | 2.26 | 2.51 | ||
| Last | 8.16 | 2.37 | 2.62 | ||
| Change | -2.59 | +0.06 | -0.05 | ||
| % Change | -24.09% | +2.60% | -1.69% | ||
| Volume | 88,500 | 182,400 | 18,000 | ||
| 20-Day Average Volume | 46,075 | 209,365 | 25,385 | ||
| Previous Close | 10.75 | 2.31 | 2.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.22 | 2.76 | 2.70 | ||
| 20-Day Raw Stochastic | 7.86% | 12.39% | 30.88% | ||
| 20-Day Relative Strength | 27.48% | 43.43% | 52.64% | ||
| Weighted Alpha | -20.21 | -19.34 | -43.10 | ||
| Today's Opinion | 8% Buy | 72% Sell | 8% Sell | ||
| Previous Opinion | 100% Buy | 72% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.11% since 03/13/23 | -1.25% since 11/15/24 | -3.86% since 11/15/24 | ||
| Low | 7.80 on 03/20/23 | 2.23 on 11/19/24 | 2.51 on 11/22/24 | ||
| High | 12.38 on 03/16/23 | 2.45 on 11/18/24 | 2.77 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | -21.91% since 02/15/23 | -15.36% since 10/22/24 | -4.21% since 10/22/24 | ||
| Low | 7.80 on 03/20/23 | 2.23 on 11/19/24 | 2.48 on 10/24/24 | ||
| High | 12.38 on 03/16/23 | 3.36 on 11/11/24 | 2.85 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | -20.00% since 12/13/22 | -15.66% since 08/22/24 | +9.87% since 08/22/24 | ||
| Low | 7.80 on 03/20/23 | 2.15 on 09/06/24 | 1.53 on 09/26/24 | ||
| High | 12.38 on 03/16/23 | 3.36 on 11/11/24 | 2.85 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | -18.73% since 09/20/22 | -34.17% since 05/22/24 | -29.70% since 05/22/24 | ||
| Low | 7.80 on 03/20/23 | 2.08 on 06/26/24 | 1.53 on 09/26/24 | ||
| High | 12.38 on 03/16/23 | 3.61 on 05/23/24 | 3.76 on 05/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 140,760 | 142,390 | 137,227 | ||
| Shares Outstanding, K | 17,250 | 60,080 | 52,477 | ||
| Annual Sales | 0 | 0 | 25,070,000 | ||
| Annual Net Income | 6,850,000 | -52,370,000 | -119,510,000 | ||
| Last Quarter Sales | 0 | 0 | 65,000 | ||
| Last Quarter Net Income | 458,470 | -29,770,000 | -14,296,000 | ||
| 60-Month Beta | 0.00 | 0.04 | 0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/14/22 | -0.50 on 11/12/24 | N/A on 09/20/21 | ||
| Latest Earnings Date | N/A | 11/12/24 | 09/25/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||